HIGHLIGHTS
- who: John D. Christie from the State University, Tempe, AZ, USA have published the paper: Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma, in the Journal: (JOURNAL) of 22/09/2021
- what: Of this study showed that the PBMC preloaded strategy was the most effective at reducing tumor burden and increasing median survival time but sequential intravenous multi-dosing with naked virus was comparably effective to a single infusion of PBMC-loaded virus. The authors explore the capacity of the systemic ex vivo delivery strategy of MYXV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.